CardioSpectral

Cardiologist with special interest in cardiac imaging, heart failure and coronary physiology/hemodynamics

[Ignacio Cruz Gonzalez @icruzgonzalez]

🚩< 1 mes para #CSCestructural2026
➡️ Casos en vivo TAVI, cierre orejuela, prótesis pulmonar, reparación mitral...
➡️ Inscripción para talleres abierto: #simulands, ICE, ... plazas limitadas!!!
➡️ Toda la info e inscripción en https://t.co/8Pxfe0RJGf
🫵 Os esperamos!

[Bashaer Gheyath MD FACC 🫀👩🏻‍⚕️ @Bgheyath]

Dr Nishimura 🫀✨This slide never gets old.
RHC hemodynamics — RA, PAWP, RA/PAWP & PAPi — remain the backbone for LV/RV/BiV failure assessment before LVAD.
Elegant physiology, real consequences.
#ICSC2026 #CardioTwitter

[NEJM @NEJM]

In patients with atrial fibrillation after successful ablation, rivaroxaban therapy did not lead to a significantly lower incidence of a composite of stroke, systemic embolism, or new covert embolic stroke than aspirin therapy. Full OCEAN trial results and Research Summary: https://t.co/jM3DdE3mUS #AFib

[Victoria Delgado @VDelgadoGarcia]

Sunday morning at #3DEchoBerlin full handson on 3D echo:
🫀LV & RV quantification
❤️mitral valve analysis
💙tricuspid valve assessment
@NMerke @eromerodorta @EACVIPresident

[Ritu Thamman MD @iamritu]

HF 3DE volumes🔑~outcomes
🔺3DE LVEF changes indication for ICD in 20% pts
🔺3DE LVEF only independent predictor of major arrhythmic events
🔺3DE RVEF associated with MACE & cardiac death
#3DEchoBerlin #echofirst

[Ahmed Bennis MD 🫀 @drbennisahmed]

Clonal haematopoiesis of indeterminate potential and mortality in coronary artery disease

Clonal haematopoiesis of indeterminate potential is a predictor of mortality in CAD patients. TET2mutations promote a pro-atherogenic macrophage phenotype via LDLR up-regulation and inflammatory activation, linking epigenetic dysregulation to adverse outcomes in CAD.

#Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare
@ESC_Journals @ehj_ed @JACCJournals

https://t.co/NwSgObqkPd

[Universidad de Salamanca @usal]

Hoy la USAL ha investido doctor #HonorisCausa a @RafaelNadal. 🎓

Un reconocimiento a su ejemplo de resiliencia, disciplina y compromiso social, valores que también guían nuestra misión universitaria. 👏

Conceptos universales que inspiran a la sociedad y nos ayudan a ser mejores científicos, artistas, autores…

💬 "En un mundo que parece estar en constante división y polarización, creo firmemente que el deporte puede ser un puente, un espacio de encuentro que promueva la convivencia, la cordialidad y el respeto mutuo”, subrayó Nadal.

💬 En su discurso, el rector @corchadojm señaló que “Nadal representa la constancia y la excelencia a su nivel máximo, esa excelencia que la Universidad procura alcanzar en todas sus acciones”.

Más información ➡️ https://t.co/7roXW1ir6q

[CardioSpectral @CardioSpectral]

@PhilippLurz TTVR offers total abolition of a TR but at a cost: it is knot known which is the best anticoagulation strategy, how to monitor o manage conduction disturbances and RV failure. It’s a much more expensive procedure. We urgently need cost-effectiveness studies.

[CardioSpectral @CardioSpectral]

@PhilippLurz T-TEER frequently leaves suboptimal results (residual TR ≥ moderate) which are clearly associated with worse prognosis https://t.co/VdlEMZONw8

[CardioSpectral @CardioSpectral]

@drjohnm @kaulcsmc Why so?

[CardioSpectral @CardioSpectral]

@MAecocardio Muy en relación con el anterior: https://t.co/QbYFoQZsY0

Tal vez merezca un comentario también?

[Cristian Herrera @CHerrera_F]

The "One-Stop-Shop" for Broken Heart Syndrome 💔

New data in @CircImaging 👇 #CardioTwitter #YesCCT #Takotsubo just published by our group @scardiosal @IBSAL_IIS @SaludISCIII @MailloSeco @AnaMartin_G @pedroluisSF
https://t.co/QKeFl36OVK

[Philipp Lurz @PhilippLurz]

@kp_rommel received the research award of the RobertMüllerStiftung paying tribute to his academic and clinical mentors, honoured to be one of those 🤩 @IngoEitel @thiele_holger !

[Vladyslav Kavalerchyk 🇺🇦 @echo_stepbystep]

Prognostic value of right ventricular longitudinal strain assessed by multimodal imaging in #amyloidosis : systematic review and meta-analysis by @EHJCVIEiC #Research
Javier Herrera-Flores et al. https://t.co/6Nh74dMS7g
@EACVIPresident @denisamuraru @lpbadano @donal @JGrapsa

[Cristian Herrera @CHerrera_F]

Team science at its best! 💪 So proud to share this comprehensive meta-analysis on the prognostic value of RV strain in #amyloidosis 📈 asssesed by multimodal imaging (echo/CMR). Honored as last author—thanks for the spotlight! https://t.co/UGSvh1bBY5 @EACVIPresident @EHJCVIEiC

[Cristian Herrera @CHerrera_F]

It is also a great honour to see our work discussed in the excellent @EHJCVIEiC editorial by @benayozbay and @SadeLeylaElif🔗 https://t.co/BVaLQzCGz1

Thank you for this outstanding contribution to the discussion! 🙏 @arjunkg @Javihf_10 @keramidakallio3 @pedroluisSF @anguita_m

[Professor Arjun Ghosh (London Cardio-Oncology) @arjunkg]

Excellent work by @Chf1992 and colleagues on this under-reported area in #cardiooncology @awechalekar @ICOSociety @BritishCardioSo

[Benay Ozbay @benayozbay]

@Chf1992 @EHJCVIEiC @arjunkg @Javihf_10 @keramidakallio3 @pedroluisSF @anguita_m Honored to comment on your excellent work, congratulations to you and your team!

[Javihf10 @Javihf_10]

@Chf1992 @arjunkg #RichardKCheng @keramidakallio3
#AshutoshWechalekar @anguita_m @pedroluisSF
@EACVIPresident @EHJCVIEiC @EHJIMPEiC @ehj_ed
@dr_m_fontana @dr_pavia @Amyloidosis_ARC @NHSBartsHealth @RoyalFreeNHS #NationalAmyloidosisCentre
⚠️Read more👉https://t.co/rsQtrkQvQS